Figures computed from official regulatory filings — .
Analysttarget 33 USD (+210%) · consensus 4.29/5 · 6 buy · 0 hold · 1 sell
Ownershipinsiders 7.97% · institutions 44.36% · short 4.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Silence Therapeutics plc only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Griffiths Richard Iantrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HELLUMS RHONDA LYNETTE | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ede-Golightly James | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Romano Steven J. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lemus David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |